nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2A6—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.0183	0.0183	CbGpPWpGaD
Buprenorphine—CYP2C8—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.0179	0.0179	CbGpPWpGaD
Buprenorphine—CYP3A5—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.0178	0.0178	CbGpPWpGaD
Buprenorphine—CYP2C18—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.016	0.016	CbGpPWpGaD
Buprenorphine—CYP2C19—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.016	0.016	CbGpPWpGaD
Buprenorphine—CYP2C8—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.0155	0.0155	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.0146	0.0146	CbGpPWpGaD
Buprenorphine—CYP2C9—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.0146	0.0146	CbGpPWpGaD
Buprenorphine—CYP3A5—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.0145	0.0145	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.014	0.014	CbGpPWpGaD
Buprenorphine—CYP2C19—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.0138	0.0138	CbGpPWpGaD
Buprenorphine—OPRM1—IL4-mediated signaling events—CD40LG—membranous glomerulonephritis	0.0128	0.0128	CbGpPWpGaD
Buprenorphine—CYP2D6—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.0127	0.0127	CbGpPWpGaD
Buprenorphine—UGT1A9—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.0126	0.0126	CbGpPWpGaD
Buprenorphine—CYP2C9—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.0126	0.0126	CbGpPWpGaD
Buprenorphine—CYP2C8—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.0125	0.0125	CbGpPWpGaD
Buprenorphine—CYP1A2—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.0124	0.0124	CbGpPWpGaD
Buprenorphine—OPRL1—G alpha (i) signalling events—C3—membranous glomerulonephritis	0.0124	0.0124	CbGpPWpGaD
Buprenorphine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.0122	0.0122	CbGpPWpGaD
Buprenorphine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.0114	0.0114	CbGpPWpGaD
Buprenorphine—CYP2C19—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.0112	0.0112	CbGpPWpGaD
Buprenorphine—CYP1A2—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.0108	0.0108	CbGpPWpGaD
Buprenorphine—CYP3A7—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.0106	0.0106	CbGpPWpGaD
Buprenorphine—UGT1A9—PPARA activates gene expression—ABCA1—membranous glomerulonephritis	0.0104	0.0104	CbGpPWpGaD
Buprenorphine—CYP2D6—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.0103	0.0103	CbGpPWpGaD
Buprenorphine—CYP2C9—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.0102	0.0102	CbGpPWpGaD
Buprenorphine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—membranous glomerulonephritis	0.0102	0.0102	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.00982	0.00982	CbGpPWpGaD
Buprenorphine—CYP2A6—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00975	0.00975	CbGpPWpGaD
Buprenorphine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.00973	0.00973	CbGpPWpGaD
Buprenorphine—CYP2C19—Melatonin metabolism and effects—APOE—membranous glomerulonephritis	0.00933	0.00933	CbGpPWpGaD
Buprenorphine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—membranous glomerulonephritis	0.00875	0.00875	CbGpPWpGaD
Buprenorphine—CYP1A2—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00872	0.00872	CbGpPWpGaD
Buprenorphine—CYP2D6—Melatonin metabolism and effects—APOE—membranous glomerulonephritis	0.00858	0.00858	CbGpPWpGaD
Buprenorphine—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.0083	0.0083	CbGpPWpGaD
Buprenorphine—CYP3A5—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00769	0.00769	CbGpPWpGaD
Buprenorphine—ABCB1—ABC-family proteins mediated transport—APOA1—membranous glomerulonephritis	0.00757	0.00757	CbGpPWpGaD
Buprenorphine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.00751	0.00751	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—C3—membranous glomerulonephritis	0.00748	0.00748	CbGpPWpGaD
Buprenorphine—CYP1A2—Melatonin metabolism and effects—APOE—membranous glomerulonephritis	0.00727	0.00727	CbGpPWpGaD
Buprenorphine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—membranous glomerulonephritis	0.007	0.007	CbGpPWpGaD
Buprenorphine—UGT1A9—PPARA activates gene expression—APOA1—membranous glomerulonephritis	0.00675	0.00675	CbGpPWpGaD
Buprenorphine—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00673	0.00673	CbGpPWpGaD
Buprenorphine—CYP2C8—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00666	0.00666	CbGpPWpGaD
Buprenorphine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—membranous glomerulonephritis	0.00661	0.00661	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CD40—membranous glomerulonephritis	0.00647	0.00647	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.00625	0.00625	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00599	0.00599	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00594	0.00594	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—HLA-DQA1—membranous glomerulonephritis	0.00562	0.00562	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.00548	0.00548	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00547	0.00547	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00542	0.00542	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—C3—membranous glomerulonephritis	0.00527	0.00527	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00525	0.00525	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—IL1B—membranous glomerulonephritis	0.005	0.005	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.00498	0.00498	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CD40LG—membranous glomerulonephritis	0.00496	0.00496	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00486	0.00486	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.00463	0.00463	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00463	0.00463	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—C3—membranous glomerulonephritis	0.00462	0.00462	CbGpPWpGaD
Buprenorphine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—membranous glomerulonephritis	0.00455	0.00455	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00444	0.00444	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—C3—membranous glomerulonephritis	0.00439	0.00439	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00433	0.00433	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—C3—membranous glomerulonephritis	0.00423	0.00423	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.00419	0.00419	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00417	0.00417	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—HLA-DRB1—membranous glomerulonephritis	0.004	0.004	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—C3—membranous glomerulonephritis	0.00391	0.00391	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—C3—membranous glomerulonephritis	0.00384	0.00384	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.00368	0.00368	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00357	0.00357	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—membranous glomerulonephritis	0.0032	0.0032	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—C3—membranous glomerulonephritis	0.00319	0.00319	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.00311	0.00311	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—PLG—membranous glomerulonephritis	0.00298	0.00298	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—RHOA—membranous glomerulonephritis	0.00298	0.00298	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—C3—membranous glomerulonephritis	0.0028	0.0028	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.00279	0.00279	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—TBXAS1—membranous glomerulonephritis	0.00274	0.00274	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—RHOA—membranous glomerulonephritis	0.00271	0.00271	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL1B—membranous glomerulonephritis	0.0026	0.0026	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00256	0.00256	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—LRP2—membranous glomerulonephritis	0.00244	0.00244	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—C3—membranous glomerulonephritis	0.00237	0.00237	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00235	0.00235	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00228	0.00228	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00228	0.00228	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—C3—membranous glomerulonephritis	0.00227	0.00227	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00219	0.00219	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—TBXAS1—membranous glomerulonephritis	0.00216	0.00216	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.00213	0.00213	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—APOE—membranous glomerulonephritis	0.00211	0.00211	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.00209	0.00209	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—APOA1—membranous glomerulonephritis	0.00209	0.00209	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00208	0.00208	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00203	0.00203	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00196	0.00196	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—LRP2—membranous glomerulonephritis	0.00193	0.00193	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.00186	0.00186	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00186	0.00186	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00185	0.00185	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—TBXAS1—membranous glomerulonephritis	0.00183	0.00183	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.00183	0.00183	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—TBXAS1—membranous glomerulonephritis	0.00182	0.00182	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.00181	0.00181	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—C3—membranous glomerulonephritis	0.0018	0.0018	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00179	0.00179	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00178	0.00178	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—TBXAS1—membranous glomerulonephritis	0.00167	0.00167	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—C3—membranous glomerulonephritis	0.00164	0.00164	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—LRP2—membranous glomerulonephritis	0.00164	0.00164	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—LRP2—membranous glomerulonephritis	0.00162	0.00162	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—RHOA—membranous glomerulonephritis	0.0016	0.0016	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00158	0.00158	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—C3—membranous glomerulonephritis	0.00158	0.00158	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.00158	0.00158	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00157	0.00157	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ABCA1—membranous glomerulonephritis	0.00157	0.00157	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00156	0.00156	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00153	0.00153	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—LRP2—membranous glomerulonephritis	0.00149	0.00149	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.00147	0.00147	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.00146	0.00146	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—C3—membranous glomerulonephritis	0.00144	0.00144	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.00144	0.00144	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00143	0.00143	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—C3—membranous glomerulonephritis	0.00134	0.00134	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—TBXAS1—membranous glomerulonephritis	0.00131	0.00131	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.00131	0.00131	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PLG—membranous glomerulonephritis	0.00127	0.00127	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—RHOA—membranous glomerulonephritis	0.00127	0.00127	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MMP9—membranous glomerulonephritis	0.00127	0.00127	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ABCA1—membranous glomerulonephritis	0.00124	0.00124	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—C3—membranous glomerulonephritis	0.00121	0.00121	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.0012	0.0012	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—LRP2—membranous glomerulonephritis	0.00117	0.00117	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.00116	0.00116	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—RHOA—membranous glomerulonephritis	0.00115	0.00115	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—TBXAS1—membranous glomerulonephritis	0.00114	0.00114	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.00113	0.00113	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00113	0.00113	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PLG—membranous glomerulonephritis	0.00112	0.00112	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—RHOA—membranous glomerulonephritis	0.00112	0.00112	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ABCA1—membranous glomerulonephritis	0.00105	0.00105	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ABCA1—membranous glomerulonephritis	0.00104	0.00104	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—APOE—membranous glomerulonephritis	0.00103	0.00103	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—APOA1—membranous glomerulonephritis	0.00102	0.00102	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.00102	0.00102	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—TBXAS1—membranous glomerulonephritis	0.00102	0.00102	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—LRP2—membranous glomerulonephritis	0.00101	0.00101	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—RHOA—membranous glomerulonephritis	0.00101	0.00101	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—TBXAS1—membranous glomerulonephritis	0.000992	0.000992	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000977	0.000977	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—C3—membranous glomerulonephritis	0.000968	0.000968	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000966	0.000966	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ABCA1—membranous glomerulonephritis	0.000957	0.000957	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000955	0.000955	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PLG—membranous glomerulonephritis	0.000944	0.000944	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—RHOA—membranous glomerulonephritis	0.000942	0.000942	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—TBXAS1—membranous glomerulonephritis	0.000935	0.000935	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—TBXAS1—membranous glomerulonephritis	0.000927	0.000927	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—LRP2—membranous glomerulonephritis	0.000906	0.000906	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—APOE—membranous glomerulonephritis	0.000901	0.000901	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000891	0.000891	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—LRP2—membranous glomerulonephritis	0.000884	0.000884	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000872	0.000872	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000862	0.000862	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—RHOA—membranous glomerulonephritis	0.000856	0.000856	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000852	0.000852	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000851	0.000851	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—C3—membranous glomerulonephritis	0.000849	0.000849	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—LRP2—membranous glomerulonephritis	0.000833	0.000833	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—LRP2—membranous glomerulonephritis	0.000826	0.000826	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—APOE—membranous glomerulonephritis	0.000817	0.000817	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ALB—membranous glomerulonephritis	0.000809	0.000809	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—APOA1—membranous glomerulonephritis	0.000807	0.000807	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000802	0.000802	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000795	0.000795	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—TBXAS1—membranous glomerulonephritis	0.000792	0.000792	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000791	0.000791	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—APOE—membranous glomerulonephritis	0.00079	0.00079	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000786	0.000786	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000781	0.000781	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000777	0.000777	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000756	0.000756	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ABCA1—membranous glomerulonephritis	0.000755	0.000755	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—C3—membranous glomerulonephritis	0.000717	0.000717	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LRP2—membranous glomerulonephritis	0.000706	0.000706	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—APOE—membranous glomerulonephritis	0.000693	0.000693	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—APOE—membranous glomerulonephritis	0.000687	0.000687	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—APOA1—membranous glomerulonephritis	0.000685	0.000685	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000682	0.000682	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000679	0.000679	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—APOA1—membranous glomerulonephritis	0.000679	0.000679	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000675	0.000675	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000672	0.000672	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOE—membranous glomerulonephritis	0.000668	0.000668	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000664	0.000664	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOA1—membranous glomerulonephritis	0.00066	0.00066	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCA1—membranous glomerulonephritis	0.000654	0.000654	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—membranous glomerulonephritis	0.00064	0.00064	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOE—membranous glomerulonephritis	0.00063	0.00063	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.000627	0.000627	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOA1—membranous glomerulonephritis	0.000622	0.000622	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000616	0.000616	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	0.000611	0.000611	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000598	0.000598	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCA1—membranous glomerulonephritis	0.000584	0.000584	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ABCA1—membranous glomerulonephritis	0.00057	0.00057	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	0.000545	0.000545	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—membranous glomerulonephritis	0.000543	0.000543	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000542	0.000542	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—membranous glomerulonephritis	0.000538	0.000538	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCA1—membranous glomerulonephritis	0.000537	0.000537	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCA1—membranous glomerulonephritis	0.000532	0.000532	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000526	0.000526	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000524	0.000524	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000506	0.000506	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOE—membranous glomerulonephritis	0.000497	0.000497	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—membranous glomerulonephritis	0.000493	0.000493	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOA1—membranous glomerulonephritis	0.000491	0.000491	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000475	0.000475	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCA1—membranous glomerulonephritis	0.000455	0.000455	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOE—membranous glomerulonephritis	0.00043	0.00043	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOA1—membranous glomerulonephritis	0.000425	0.000425	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000401	0.000401	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—membranous glomerulonephritis	0.000389	0.000389	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOE—membranous glomerulonephritis	0.000384	0.000384	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOA1—membranous glomerulonephritis	0.00038	0.00038	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOE—membranous glomerulonephritis	0.000375	0.000375	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOA1—membranous glomerulonephritis	0.00037	0.00037	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOE—membranous glomerulonephritis	0.000353	0.000353	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	0.000351	0.000351	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOE—membranous glomerulonephritis	0.00035	0.00035	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOA1—membranous glomerulonephritis	0.000349	0.000349	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOA1—membranous glomerulonephritis	0.000346	0.000346	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—membranous glomerulonephritis	0.000337	0.000337	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—membranous glomerulonephritis	0.000301	0.000301	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOE—membranous glomerulonephritis	0.000299	0.000299	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOA1—membranous glomerulonephritis	0.000296	0.000296	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—membranous glomerulonephritis	0.000293	0.000293	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—membranous glomerulonephritis	0.000277	0.000277	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—membranous glomerulonephritis	0.000274	0.000274	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—membranous glomerulonephritis	0.000234	0.000234	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	0.000231	0.000231	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	0.000228	0.000228	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	0.000181	0.000181	CbGpPWpGaD
